Sebastian Havervall

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1346749
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Bladh O; Aguilera K; Marking U; Kihlgren M; Norin NG; Smed-Sorensen A; Chen MS; Klingstrom J; Blom K; Russell MW; Havervall S; Thalin C; Aberg M
Article: NATURE COMMUNICATIONS. 2023;14(1):1577
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U; Havervall S; Norin NG; Bladh O; Christ W; Gordon M; Ng H; Blom K; Phillipson M; Mangsbo S; Alm JJ; Smed-Sorensen A; Nilsson P; Hober S; Aberg M; Klingstroem J; Thalin C
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2023;7(3):100124
Tissue factor activity of small and large extracellular vesicles in different diseases
Sachetto ATA; Archibald SJ; Hisada Y; Rosell A; Havervall S; van Es N; Nieuwland R; Campbell RA; Middleton EA; Rondina MT; Thalin C; Mackman N
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(5):e13215
Impact of monocyte-related modulators and kidney function on mortality in hospitalized patients with COVID-19
Sendic S; Mansouri L; Havervall S; Thalin C; Lundahl J; Jacobson SH
Article: CYTOKINE. 2022;159:156020
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
Ziegler L; Lundstrom A; Havervall S; Thalin C; Gigante B
Article: BMC NEPHROLOGY. 2022;23(1):299
"Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19"
Mansouri L; Sendic S; Havervall S; Thalin C; Jacobson SH; Lundahl J
Article: EMBO MOLECULAR MEDICINE. 2022;14(8):e15230
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
Monteil V; Eaton B; Postnikova E; Murphy M; Braunsfeld B; Crozier I; Kricek F; Niederhofer J; Schwarzbock A; Breid H; Devignot S; Klingstrom J; Thalin C; Kellner MJ; Christ W; Havervall S; Mereiter S; Knapp S; Jimenez AS; Bugajska-Schretter A; Dohnal A; Ruf C; Gugenberger R; Hagelkruys A; Montserrat N; Kozieradzki I; Ali OH; Stadlmann J; Holbrook MR; Schmaljohn C; Oostenbrink C; Shoemaker RH; Mirazimi A; Wirnsberger G; Penninger JM
Article: IMMUNITY, INFLAMMATION AND DISEASE. 2022;10(4):e595
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
Lauren I; Havervall S; Ng H; Lord M; Pettke A; Greilert-Norin N; Gabrielsson L; Chourlia A; Amoedo-Leite C; Josyula VS; Eltahir M; Kerzeli I; Falk AJ; Hober J; Christ W; Wiberg A; Hedhammar M; Tegel H; Burman J; Xu F; Pin E; Manberg A; Klingstrom J; Christoffersson G; Hober S; Nilsson P; Philipson M; Donnes P; Lindsay R; Thalin C; Mangsbo S
Article: VACCINES. 2022;10(3):359
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
Marking U; Havervall S; Greilert-Norin N; Ng H; Blom K; Nilsson P; Phillipson M; Hober S; Nilsson C; Mangsbo S; Christ W; Klingstrom J; Gordon M; Aberg M; Thalin C
Article: NEW BIOTECHNOLOGY. 2022;66:46-52
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
Mravinacova S; Jonsson M; Christ W; Klingstrom J; Yousef J; Hellstrom C; Hedhammar M; Havervall S; Thalin C; Pin E; Tegel H; Nilsson P; Manberg A; Hober S
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2022;11(4):e1388
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
Havervall S; Marking U; Greilert-Norin N; Gordon M; Ng H; Christ W; Phillipson M; Nilsson P; Hober S; Blom K; Klingstrom J; Mangsbo S; Aberg M; Thalin C
Article: PLOS ONE. 2022;17(1):e0262169
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S; Falk AJ; Klingstrom J; Ng H; Greilert-Norin N; Gabrielsson L; Salomonsson A-C; Isaksson E; Rudberg A-S; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Christ W; Olausson M; Hedhammar M; Tegel H; Mangsbo S; Phillipson M; Manberg A; Hober S; Nilsson P; Thalin C
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):72-80
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Manberg A; Marking U; Lauren I; Gabrielsson L; Salomonsson A-C; Aguilera K; Kihlgren M; Mansson M; Rosell A; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Aberg M; Hedhammar M; Tegel H; Donnes P; Phillipson M; Nilsson P; Klingstrom J; Mangsbo S; Hober S; Thalin C
Article: JOURNAL OF MEDICAL VIROLOGY. 2021;93(10):5908-5916
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers
Lundstrom A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sanden P; Thalin C
Article: SCIENTIFIC REPORTS. 2021;11(1):18025
Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
Zenlander R; Havervall S; Magnusson M; Engstrand J; Agren A; Thalin C; Stal P
Article: EBIOMEDICINE. 2021;70:103523
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson A-C; Hellstrom C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingstrom J; Hober S; Nilsson P; Aberg M; Thalin C
Article: SCIENTIFIC REPORTS. 2021;11(1):14015
An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism
Razzaq M; Iglesias MJ; Ibrahim-Kosta M; Goumidi L; Soukarieh O; Proust C; Roux M; Suchon P; Boland A; Daiain D; Olaso R; Havervall S; Thalin C; Butler L; Deleuze J-F; Odeberg J; Morange P-E; Tregouet D-A
Article: NATURE COMMUNICATIONS. 2021;12(1):3695
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2
Roxhed N; Bendes A; Dale M; Mattsson C; Hanke L; Dodig-Crnkovic T; Christian M; Meineke B; Elsasser S; Andrell J; Havervall S; Thalin C; Eklund C; Dillner J; Beck O; Thomas CE; McInerney G; Hong M-G; Murrell B; Fredolini C; Schwenk JM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):878-882
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report
Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thalin C
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):988-994
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19
Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thalin C; Phillipson M
Article: PLOS ONE. 2021;16(9):e0258041
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
Mangsbo SM; Havervall S; Lauren I; Lindsay R; Falk AJ; Marking U; Lord M; Buggert M; Donnes P; Christoffersson G; Nilsson P; Hober S; Phillipson M; Klingstrom J; Thalin C
Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021;11:795026
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation
Heber S; Pereyra D; Schrottmaier WC; Kammerer K; Santol J; Rumpf B; Pawelka E; Hanna M; Scholz A; Liu M; Hell A; Heiplik K; Lickefett B; Havervall S; Traugott MT; Neuboeck MJ; Schoergenhofer C; Seitz T; Firbas C; Karolyi M; Weiss G; Jilma B; Thalin C; Bellmann-Weiler R; Salzer HJF; Szepannek G; Fischer MJM; Zoufaly A; Gleiss A; Assinger A
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1312
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay
Hober S; Hellstrom C; Olofsson J; Andersson E; Bergstrom S; Jernbom Falk A; Bayati S; Mravinacova S; Sjoberg R; Yousef J; Skoglund L; Kanje S; Berling A; Svensson A-S; Jensen G; Enstedt H; Afshari D; Xu LL; Zwahlen M; von Feilitzen K; Hanke L; Murrell B; McInerney G; Karlsson Hedestam GB; Lendel C; Roth RG; Skoog I; Svenungsson E; Olsson T; Fogdell-Hahn A; Lindroth Y; Lundgren M; Maleki KT; Lagerqvist N; Klingstrom J; Da Silva Rodrigues R; Muschiol S; Bogdanovic G; Arroyo Muhr LS; Eklund C; Lagheden C; Dillner J; Sivertsson A; Havervall S; Thalin C; Tegel H; Pin E; Manberg A; Hedhammar M; Nilsson P
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2021;5(1):132-141
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Rudberg A-S; Magnusson M; Mackman N; Thalin C; Lisman T
Article: NATURE COMMUNICATIONS. 2020;11(1):5064
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg A-S; Havervall S; Manberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson A-C; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellstrom C; Bayati S; Bergstrom S; Pin E; Sjoberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thalin C
Visa fler

Alla övriga publikationer

Thesis / dissertation: 2024
Immune responses after SARS-CoV-2 infection and/or vaccination
Havervall, Sebastian
Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2024;38:100872
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
Aguilera K; Bladh O; Marking U; Norin NG; Rihani A; Ujvari D; Ning FC; Klingstroem J; Havervall S; Aberg M; Blom K; Alm JJ; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2024;24(2):e80-e81
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2023;389(17):1626-1628
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection
Bladh O; Greilert-Norin N; Havervall S; Marking U; Aguilera K; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2023;33:100725
Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
Blom K; Bladh O; Havervall S; Marking U; Norin NG; Alm JJ; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(8):e272-e273
Mucosal IgA protects against BQ.1 and BQ.1.1 infection
Marking U; Bladh O; Havervall S; Greilert-Norin N; Gordon M; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET MICROBE. 2023;4(7):e488
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Bladh O; Marking U; Havervall S; Norin NG; Aguilera K; Hober S; Smed-Soerensen A; Gordon M; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(2):150-152
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Marking U; Bladh O; Havervall S; Svensson J; Greilert-Norin N; Aguilera K; Kihlgren M; Salomonsson A-C; Mansson M; Gallini R; Kriegholm C; Bacchus P; Hober S; Gordon M; Blom K; Smed-Sorensen A; Aberg M; Klingstrom J; Thalin C
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(14):1333-1336
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
Havervall S; Marking U; Svensson J; Greilert-Norin N; Bacchus P; Nilsson P; Hober S; Gordon M; Blom K; Klingstrom J; Aberg M; Smed-Sorensen A; Thalin C
Letter: EMERGING INFECTIOUS DISEASES. 2022;28(10):2119-2121
Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
Blom K; Havervall S; Marking U; Norin NG; Bacchus P; Groenheit R; Brave A; Thalin C; Klingstrom J
Letter: THE LANCET INFECTIOUS DISEASES. 2022;22(7):943-945
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
Blom K; Marking U; Havervall S; Norin NG; Gordon M; Garcia M; Tecleab T; Christ W; Forsell M; Phillipson M; Nilsson P; Mangsbo S; Hober S; Aberg M; Klingstrom J; Thalin C
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2022;20(1):267-269
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al.
von Meijenfeldt FA; Havervall S; Adelmeijer J; Thalin C; Lisman T
Letter: THROMBOSIS AND HAEMOSTASIS. 2021;121(12):1668-1669
COVID-19 is Associated with an Acquired Factor XIII Deficiency
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):e381-e382
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"
Mackman N; Hisada Y; Grover SP; Rosell A; Havervall S; von Meijenfeldt F; Aguilera K; Lisman T; Thalin C
Letter: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2021;325(19):2015-2016
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
Havervall S; Rosell A; Phillipson M; Mangsbo SM; Nilsson P; Hober S; Thalin C
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(4):E98-E100
Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
Letter: BLOOD ADVANCES. 2021;5(3):756-759
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T

Anställningar

Doktorand, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2022-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2024

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI